Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology

European Journal of Neuroscience

Volumn 30, Issue 9, 2009, Pages 1823-1830

  Leduc, Valérie ^a,b   Théroux, Louise ^a   Dea, Doris ^a   Robitaille, Yves ^c   Poirier, Judes ^a,d  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

amyloid; Central nervous system lipid homeostasis; Choline acetyltransferase activity; Genetic risk factor; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN; ARYLDIALKYLPHOSPHATASE 1; CHOLINE ACETYLTRANSFERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PON1 GENE; PRIORITY JOURNAL; SENILE PLAQUE; SEX DIFFERENCE; SURVIVAL TIME;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ARYLDIALKYLPHOSPHATASE; BRAIN; CHOLINE O-ACETYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 70350787098     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06983.x     Document Type: Article

References (62)

1. Andersen, K., Launer, L.J., Dewey, M.E., Letenneur, L., Ott, A., Copeland, J.R., Dartigues, J.F., Kragh-Sorensen, P., Baldereschi, M., Brayne, C., Lobo, A., Martinez-Lage, J.M., Stijnen, T. Hofman, A. (1999) Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group. Neurology, 53, 1992 1997.
2. Andreotti, F. Marchese, N. (2008) Women and coronary disease. Heart, 94, 108 116.
3. Aubert, I., Araujo, D.M., Cecyre, D., Robitaille, Y., Gauthier, S. Quirion, R. (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem., 58, 529 541.
4. Aviram, M., Rosenblat, M., Bisgaier, C.L., Newton, R.S., Primo-Parmo, S.L. La Du, B.N. (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest., 101, 1581 1590.
5. Beffert, U., Arguin, C. Poirier, J. (1999a) The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease. Neurosci. Lett., 259, 29 32.
6. Beffert, U., Cohn, J.S., Petit-Turcotte, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J. Poirier, J. (1999b) Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res., 843, 87 94.
7. Bertram, L., McQueen, M.B., Mullin, K., Blacker, D. Tanzi, R.E. (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet., 39, 17 23.
8. Bettens, K., Brouwers, N., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C. Sleegers, K. (2008) SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum. Mutat., 29, 769 770.
9. Bjorling, E., Lindskog, C., Oksvold, P., Linne, J., Kampf, C., Hober, S., Uhlen, M. Ponten, F. (2008) A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol. Cell Proteomics, 7, 825 844.
10. Blain, J.F., Aumont, N., Theroux, L., Dea, D. Poirier, J. (2006) A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology. Eur. J. Neurosci., 24, 1245 1251.
11. Brophy, V.H., Jampsa, R.L., Clendenning, J.B., McKinstry, L.A., Jarvik, G.P. Furlong, C.E. (2001) Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am. J. Hum. Genet., 68, 1428 1436.
12. Bryk, B., BenMoyal-Segal, L., Podoly, E., Livnah, O., Eisenkraft, A., Luria, S., Cohen, A., Yehezkelli, Y., Hourvitz, A. Soreq, H. (2005) Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. J. Neurochem., 92, 1216 1227.
13. Carlson, C.S., Heagerty, P.J., Hatsukami, T.S., Richter, R.J., Ranchalis, J., Lewis, J., Bacus, T.J., McKinstry, L.A., Schellenberg, G.D., Rieder, M., Nickerson, D., Furlong, C.E., Chait, A. Jarvik, G.P. (2006) TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease. J. Lipid Res., 47, 1014 1024.
14. Cellini, E., Tedde, A., Bagnoli, S., Nacmias, B., Piacentini, S., Bessi, V., Bracco, L. Sorbi, S. (2006) Association analysis of the paraoxonase-1 gene with Alzheimer's disease. Neurosci. Lett., 408, 199 202.
15. Chapuis, J., Boscher, M., Bensemain, F., Cottel, D., Amouyel, P. Lambert, J.C. (2009) Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease. Neurobiol. Aging, 30, 152 156.
16. Dantoine, T.F., Debord, J., Merle, L., Lacroix-Ramiandrisoa, H., Bourzeix, L. Charmes, J.P. (2002a) Paraoxonase 1 activity: a new vascular marker of dementia? Ann. NY Acad. Sci., 977, 96 101.
17. Dantoine, T.F., Drouet, M., Debord, J., Merle, L., Cogne, M. Charmes, J.P. (2002b) Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. Ann. NY Acad. Sci., 977, 239 244.
18. Draczynska-Lusiak, B., Doung, A. Sun, A.Y. (1998) Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropathol., 33, 139 148.
19. Erlich, P.M., Lunetta, K.L., Cupples, L.A., Huyck, M., Green, R.C., Baldwin, C.T. Farrer, L.A. (2006) Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum. Mol. Genet., 15, 77 85.
20. Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N.P. Quirion, R. (1986) Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience, 19, 1279 1291.
21. Fratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A. Winblad, B. (1997) Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology, 48, 132 138. (Pubitemid 27039531)
22. Garin, M.C., James, R.W., Dussoix, P., Blanche, H., Passa, P., Froguel, P. Ruiz, J. (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest., 99, 62 66.
23. Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A. Pedersen, N.L. (2006) Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry, 63, 168 174.
24. Gu, F., Zhu, M., Shi, J., Hu, Y. Zhao, Z. (2008) Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice. Neurosci. Lett., 440, 44 48.
25. Harel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R.B., McCarthy, A., Toker, L., Silman, I., Sussman, J.L. Tawfik, D.S. (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol., 11, 412 419.
26. He, X.M., Zhang, Z.X., Zhang, J.W., Zhou, Y.T., Tang, M.N., Wu, C.B. Hong, Z. (2006) Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population. Chin. Med. J., 119, 1204 1209.
27. Helbecque, N., Cottel, D., Codron, V., Berr, C. Amouyel, P. (2004) Paraoxonase 1 gene polymorphisms and dementia in humans. Neurosci. Lett., 358, 41 44.
28. Heyer, E. Tremblay, M. (1995) Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am. J. Hum. Genet., 56, 970 978.
29. Hollenbach, E., Ackermann, S., Hyman, B.T. Rebeck, G.W. (1998) Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology, 50, 1905 1907.
30. Jarvik, G.P., Rozek, L.S., Brophy, V.H., Hatsukami, T.S., Richter, R.J., Schellenberg, G.D. Furlong, C.E. (2000) Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler. Thromb. Vasc. Biol., 20, 2441 2447.
31. Khachaturian, Z.S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol., 42, 1097 1105.
32. Kiechl, S., Willeit, J., Mayr, M., Viehweider, B., Oberhollenzer, M., Kronenberg, F., Wiedermann, C.J., Oberthaler, S., Xu, Q., Witztum, J.L. Tsimikas, S. (2007) Oxidized phospholipids, lipoprotein(a), lipoprotein- associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler. Thromb. Vasc. Biol., 27, 1788 1795.
33. Kim, K.W., Jhoo, J.H., Lee, K.U., Lee, D.Y., Lee, J.H., Youn, J.Y., Lee, B.J., Han, S.H. Woo, J.I. (1999) Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans. Neurosci. Lett., 277, 145 148.
34. Kivatinitz, S.C., Pelsman, M.A., Alonso, A.C., Bagatolli, L. Quiroga, S. (1997) High-density lipoprotein aggregated by oxidation induces degeneration of neuronal cells. J. Neurochem., 69, 2102 2114.
35. Knapp, S., Matt, U., Leitinger, N. van der Poll, T. (2007) Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J. Immunol., 178, 993 1001.
36. Leduc, V. Poirier, J. (2008) Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels. Neurodegener. Dis., 5, 225 227.
37. Leviev, I. James, R.W. (2000) Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol., 20, 516 521.
38. Li, H., Wetten, S., Li, L., St Jean, P.L., Upmanyu, R., Surh, L., Hosford, D., Barnes, M.R., Briley, J.D., Borrie, M., Coletta, N., Delisle, R., Dhalla, D., Ehm, M.G., Feldman, H.H., Fornazzari, L., Gauthier, S., Goodgame, N., Guzman, D., Hammond, S., Hollingworth, P., Hsiung, G.Y., Johnson, J., Kelly, D.D., Keren, R., Kertesz, A., King, K.S., Lovestone, S., Loy-English, I., Matthews, P.M., Owen, M.J., Plumpton, M., Pryse-Phillips, W., Prinjha, R.K., Richardson, J.C., Saunders, A., Slater, A.J., St George-Hyslop, P.H., Stinnett, S.W., Swartz, J.E., Taylor, R.L., Wherrett, J., Williams, J., Yarnall, D.P., Gibson, R.A., Irizarry, M.C., Middleton, L.T. Roses, A.D. (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol., 65, 45 53.
39. Mackness, M.I., Arrol, S. Durrington, P.N. (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett., 286, 152 154.
40. Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltran, R., Joven, J. Camps, J. (2008) Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic. Biol. Med., 45, 146 157.
41. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939 944.
42. Morel, D.W. (1994) Reduced cholesterol efflux to mildly oxidized high density lipoprotein. Biochem. Biophys. Res. Commun., 200, 408 416.
43. Nagano, Y., Arai, H. Kita, T. (1991) High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl Acad. Sci. USA, 88, 6457 6461.
44. Nalbantoglu, J., Gilfix, B.M., Bertrand, P., Robitaille, Y., Gauthier, S., Rosenblatt, D.S. Poirier, J. (1994) Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann. Neurol., 36, 889 895.
45. Ng, C.J., Shih, D.M., Hama, S.Y., Villa, N., Navab, M. Reddy, S.T. (2005) The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med., 38, 153 163.
46. Paragh, G., Balla, P., Katona, E., Seres, I., Egerhazi, A. Degrell, I. (2002) Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci., 252, 63 67.
47. Poirier, J. (2000) Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann. NY Acad. Sci., 924, 81 90.
48. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. Gauthier, S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet, 342, 697 699.
49. Pola, R., Gaetani, E., Flex, A., Gerardino, L., Aloi, F., Flore, R., Serricchio, M., Pola, P. Bernabei, R. (2003) Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population. Dement. Geriatr. Cogn. Disord., 15, 88 91.
50. Pola, R., Flex, A., Ciaburri, M., Rovella, E., Valiani, A., Reali, G., Silveri, M.C. Bernabei, R. (2005) Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene. Neurosci. Lett., 382, 338 341.
51. Reed, T., Perluigi, M., Sultana, R., Pierce, W.M., Klein, J.B., Turner, D.M., Coccia, R., Markesbery, W.R. Butterfield, D.A. (2008) Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol. Dis., 30, 107 120.
52. Rifici, V.A. Khachadurian, A.K. (1996) Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim. Biophys. Acta, 1299, 87 94.
53. Sasieni, P.D. (1997) From genotypes to genes: doubling the sample size. Biometrics, 53, 1253 1261.
54. Scacchi, R., Gambina, G., Martini, M.C., Broggio, E., Vilardo, T. Corbo, R.M. (2003) Different pattern of association of paraoxonase Gln192→Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease. Neurosci. Lett., 339, 17 20.
55. + allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease. Neurosci. Lett., 367, 177 180.
56. Shi, J.J., Zhang, S.Z., Ma, C., Tang, M.N., Liu, X.H., Wang, Y.C., Han, H.Y., Guo, Y.B., Feng, R.M. Miao, G.D. (2004) Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease [in Chinese]. Di Yi Jun Yi Da Xue Xue Bao, 24, 371 374.
57. Sodeyama, N., Yamada, M., Itoh, Y., Suematsu, N., Matsushita, M., Otomo, E. Mizusawa, H. (1999) No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease. Neurology, 53, 1146 1148.
58. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. Roses, A.D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA, 90, 1977 1981.
59. Sultana, R., Perluigi, M. Butterfield, D.A. (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal., 8, 2021 2037.
60. Walsh, D.M. Selkoe, D.J. (2007) A beta oligomers - a decade of discovery. J. Neurochem., 101, 1172 1184.
61. Zou, F., Gopalraj, R.K., Lok, J., Zhu, H., Ling, I.F., Simpson, J.F., Tucker, H.M., Kelly, J.F., Younkin, S.G., Dickson, D.W., Petersen, R.C., Graff-Radford, N.R., Bennett, D.A., Crook, J.E. Estus, S. (2008) Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum. Mol. Genet., 17, 929 935.
62. Zuliani, G., Ble, A., Zanca, R., Munari, M.R., Zurlo, A., Vavalle, C., Atti, A.R. Fellin, R. (2001) Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol. Scand., 103, 304 308. (Pubitemid 32368006)